December 8, 2021

Podcast Feature: Innovating for Faster Clinical Research

The Covid-19 pandemic put thousands of clinical trials on hold, but it also showed pharma companies, regulators and clinicians that decentralized clinical trials are a less expensive, more convenient and equally as effective method for generating clinical research. Dessiree Paoli, Sr. Solutions Marketing Manager for Interlace Health, joined The Healthcare Solutions Podcast to discuss how decentralized clinical trials are improving engagement with study participants, improving data capture and shortening time to market for crucial drugs.

Listen to the full Podcast

Support remote clinical trials with Interlace Health

Interlace Health’s Clinical Trial Consent Solution provides the digital platform to collect and store consent of clinical trial participants and serves as a portal to access vital educational content needed to understand trial requirements.

Our end-to-end solution allows you to digitally consent a participant anywhere, any time, and on any device enabling seamless workflows for optimal outcomes and measurable ROI. As many researchers have moved clinical trials to a virtual format,  Interlace Health’s Clinical Trial Consent Solution safely provides information to participants remotely to continue trial enrollment during this unprecedented time of quarantines, travel restrictions, and restricted site visits.

Related Topics

BlogInsightsNews and EventsThought Leadership

Recent Posts